Alimera Sciences Investor Relations Material
Latest events
Q1 2024
Alimera Sciences
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Alimera Sciences Inc
Access all reports
Alimera Sciences Inc. is a pharmaceutical company focused on the development and commercialization of prescription ophthalmic treatments. The company specializes in therapies for retinal diseases, aiming to improve vision and quality of life for patients. The company is headquartered in Alpharetta, Georgia, and its shares are listed on the NASDAQ.
Latest articles
)
The Rise and Fall of Wirecard
A look inside the Wirecard scandal, which took the company from the prestigious DAX 30 to insolvency through the largest accounting fraud in European history.
16 May 2025
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
Ticker symbol
ALIM
Country
🇺🇸 United States